Skip To Main Content
Cost-Effectiveness Programme on Muck Rack

Cost-Effectiveness Programme

As seen in: PLOS Medicine, The Lancet, Lung Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Cost-Effectiveness

Contact Cost-Effectiveness, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Disease-related income and economic productivity loss in New Zealand: A longitudinal analysis of linked individual-level data

|
By Tony Blakely, Cost-Effectiveness Programme, Finn Sigglekow
| PLOS Medicine Verified
Loading metrics Open Access Peer-reviewed Research Article Tony Blakely , Finn Sigglekow, Muhammad Irfan, Anja Mizdrak, Joseph Dieleman, Laxman Bablani, Philip Clarke, Nick Wilson Tony Blakely, Finn Sigglekow, Muhammad Irfan, Anja Mizdrak, Joseph Dieleman, Laxman Bablani, Philip Clarke, Nick Wilson Published: November 30, 2021 https://doi.org/10.1371/journal.pmed.1003848 Figures Abstract Background Reducing disease can maintain personal individual income and improve societal economic...
Open in Who Shared Issue with article?

The effect of food taxes and subsidies on population health and health costs: a modelling study

|
By Tony Blakely, Christine Cleghorn, Cost-Effectiveness Programme
| The Lancet Verified
At the level of 23 food groups, there is still important heterogeneity within food groups in product-level concentrations of sugar and saturated fat. For example, full-fat and low-fat versions of dairy products should be taxed differently, and it was necessary to allow for shifts in purchasing within the dairy food group.
Open in Who Shared Issue with article?

Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand

|
By Richard Jaine, Cost-Effectiveness Programme, Giorgi Kvizhinadze
| Lung Cancer Verified
1. Introduction While lung cancer isn’t the most common cancer in New Zealand, it is the most deadly cancer, accounting for almost 20 % of all cancer deaths in New Zealand [1x[1]Ministry of Health. Cancer: New Registrations and Deaths 2012. Ministry of Health, Wellington; 2015 Google ScholarSee all References1]. Lung cancer carries a high mortality because it is usually detected at a late stage, when the disease is advanced, spread to other parts of the body, with low survival.
Open in Who Shared Issue with article?
See all 5 articles